MX9301269A - Proteina de transferencia de triglicerido microsomal. - Google Patents

Proteina de transferencia de triglicerido microsomal.

Info

Publication number
MX9301269A
MX9301269A MX9301269A MX9301269A MX9301269A MX 9301269 A MX9301269 A MX 9301269A MX 9301269 A MX9301269 A MX 9301269A MX 9301269 A MX9301269 A MX 9301269A MX 9301269 A MX9301269 A MX 9301269A
Authority
MX
Mexico
Prior art keywords
transfer protein
microsomal triglyceride
triglyceride transfer
methods
activity
Prior art date
Application number
MX9301269A
Other languages
English (en)
Inventor
John R Ii Wetterau
Daru Young Sharp
Richard E Gregg
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25300790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9301269(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of MX9301269A publication Critical patent/MX9301269A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Vascular Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

La presente invención se relaciona con las secuencias de ácido nucléico, particularmente las secuencias de ADN, que codifican para toda o parte de la subunidad de alto peso molecular de la proteína de transferencia de triglicérido microsomal, los vectores de expresión que contienen las secuencias de ADN, las células huésped que contienen los vectores de expresión, y los método para utilizar esos materiales.
MX9301269A 1992-03-06 1993-03-08 Proteina de transferencia de triglicerido microsomal. MX9301269A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84750392A 1992-03-06 1992-03-06

Publications (1)

Publication Number Publication Date
MX9301269A true MX9301269A (es) 1993-09-01

Family

ID=25300790

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301269A MX9301269A (es) 1992-03-06 1993-03-08 Proteina de transferencia de triglicerido microsomal.

Country Status (12)

Country Link
EP (1) EP0584446B2 (es)
JP (1) JP4298801B2 (es)
AT (1) ATE219514T1 (es)
AU (1) AU670930B2 (es)
CA (1) CA2091102C (es)
DE (1) DE69332041T3 (es)
DK (1) DK0584446T4 (es)
ES (1) ES2178640T5 (es)
HU (1) HU218419B (es)
MX (1) MX9301269A (es)
PT (1) PT584446E (es)
ZA (1) ZA931601B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
ZA961340B (en) 1995-02-21 1997-09-11 Bristol Myers Squibb Co Inhibitors of microsomal triglyceride transfer protein and method.
EP0902785B1 (en) * 1996-04-30 2002-09-04 Pfizer Inc. Processes and intermediates for preparing 4'-trifluoromethylbiphenyl-2-carboxylic acid 2-(2h- 1,2,4]triazol-3-ylmethyl)-1,2,3,4-tetrahydro-isoquinolin-6-yl]-amide
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5885983A (en) * 1996-05-10 1999-03-23 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
JP2002513379A (ja) * 1996-07-24 2002-05-08 ブリストル―マイヤーズ・スクイブ・カンパニー Ｍｔｐ抑制因子を用いる、高ｌｄｌの必要を持つ腫瘍の治療法
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
WO1998031366A1 (en) * 1997-01-17 1998-07-23 Bristol-Myers Squibb Company Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs
CA2286341A1 (en) * 1997-05-01 1998-11-12 John R. Ii Wetterau Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
US5968950A (en) * 1997-06-23 1999-10-19 Pfizer Inc Apo B-secretion/MTP inhibitor hydrochloride salt
JP2959765B2 (ja) 1997-12-12 1999-10-06 日本たばこ産業株式会社 ３−ピペリジル−４−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
CA2324800A1 (en) * 1999-11-10 2001-05-10 Mary Anne Hickman Use of apo b secretion/mtp inhibitors
EP1294943A2 (en) * 2000-01-20 2003-03-26 Genome Therapeutics Corporation RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
JO2390B1 (en) 2001-04-06 2007-06-17 شركة جانسين فارماسوتيكا ان. في Diphenylcarboxamides act as lipid-lowering agents
ES2307799T3 (es) 2001-06-28 2008-12-01 Pfizer Products Inc. Benzotiofenos, benzofuranos e indoles sustituidos con triamida como inhibidores de la proteina de transferencia de trigliceridos microsomal (mtp) y/o la secrecion de la apoliproteina b (apo b).
ATE443156T1 (de) * 2003-06-27 2009-10-15 Univ New York State Res Found Fluoreszenz-assay für mtp-aktivität
AU2005214159A1 (en) 2004-02-04 2005-09-01 Pfizer Products Inc. Substituted quinoline compounds
AU2005221656B2 (en) 2004-03-05 2011-06-23 The Trustees Of The University Of Pennsylvania Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291205B1 (en) * 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae

Also Published As

Publication number Publication date
AU670930B2 (en) 1996-08-08
ES2178640T3 (es) 2003-01-01
DK0584446T4 (da) 2010-05-17
EP0584446B2 (en) 2010-03-10
JPH0638761A (ja) 1994-02-15
CA2091102C (en) 2009-05-26
ES2178640T5 (es) 2010-06-01
EP0584446A2 (en) 1994-03-02
DK0584446T3 (da) 2002-10-14
CA2091102A1 (en) 1993-09-07
ATE219514T1 (de) 2002-07-15
ZA931601B (en) 1993-10-05
HUT67962A (en) 1995-05-29
AU3406493A (en) 1993-09-09
JP4298801B2 (ja) 2009-07-22
HU9300627D0 (en) 1993-05-28
HU218419B (hu) 2000-08-28
PT584446E (pt) 2002-09-30
DE69332041T3 (de) 2011-05-05
DE69332041D1 (de) 2002-07-25
EP0584446A3 (en) 1995-04-26
EP0584446B1 (en) 2002-06-19
DE69332041T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
ES2178640T3 (es) Proteina de transferencia de trigliceridos micro9somicos.
EP0804609A4 (en) NEW GENES OF RESPONSE p53
NO931889L (no) Protease og beslektede DNA-forbindelser
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
FI885504A (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
ATE184052T1 (de) Gdf-1 und uog1 proteine
DE69435038D1 (de) Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie
NO179412C (no) Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein
ATE342911T1 (de) Synthese von nukleosiden und polynukleotiden
ATE45767T1 (de) Dns molekuele enthaltend die gene fuer preprochymosin und dessen reifungsformen und dadurch transformierte mikroorganismen.
ATE487737T1 (de) 32 humane sekretierte proteine
DE69033756D1 (de) Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
ATE193324T1 (de) Rekombinante herstellung von laktoperoxidase
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
ATE327334T1 (de) Atp- und nukleinsäure-bindendes protein mit helikase- und atpase eigenschaften
BR9810643A (pt) Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.